44 related articles for article (PubMed ID: 30559846)
1. Comparison of chromogenic in situ hybridisation with fluorescence in situ hybridisation and immunohistochemistry for the assessment of her-2/neu oncogene in archival material of breast carcinoma.
Pothos A; Plastira K; Plastiras A; Vlachodimitropoulos D; Goutas N; Angelopoulou R
Acta Histochem Cytochem; 2008 Jun; 41(3):59-64. PubMed ID: 18636112
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of HER2 Positivity Based on Clinicopathological Findings in HER2 Borderline Tumors in Iranian Patients with Breast Cancer.
Omranipour R; Nazarian N; Alipour S; Abdollahi A; Eslami B
Iran J Pathol; 2023; 18(4):403-409. PubMed ID: 38024548
[TBL] [Abstract][Full Text] [Related]
3. HER2/positive and HER2/low in inflammatory breast cancer recurrence.
Movchan OV; Bagmut IY; Shipko AF; Smolanka Senior II; Sheremet MI; Kolisnyk IL; Bagmut OV; Lyashenko AO; Loboda AD; Ivankova OM; Dosenko IV; Lazaruk OV; Gyrla YV; Bilookyi OV
J Med Life; 2022 Dec; 15(12):1573-1578. PubMed ID: 36762329
[TBL] [Abstract][Full Text] [Related]
4. Chromogenic In Situ Hybridization (CISH) as a Method for Detection of C-Myc Amplification in Formalin-Fixed Paraffin-Embedded Tumor Tissue: An Update.
Todorović-Raković N
Methods Mol Biol; 2021; 2318():313-320. PubMed ID: 34019299
[TBL] [Abstract][Full Text] [Related]
5. Potential of modern circulating cell-free DNA diagnostic tools for detection of specific tumour cells in clinical practice.
Gašperšič J; Videtič Paska A
Biochem Med (Zagreb); 2020 Oct; 30(3):030504. PubMed ID: 32774122
[TBL] [Abstract][Full Text] [Related]
6. [HER-2 oncogene amplification assessment in invasive breast cancer by dual-color in situ hybridization (dc-CISH): a comparative study with fluorescent in situ hybridization (FISH)].
Akhdar A; Bronsard M; Lemieux R; Geha S
Ann Pathol; 2011 Dec; 31(6):472-9. PubMed ID: 22172120
[TBL] [Abstract][Full Text] [Related]
7. Evaluating
Atabati H; Raoofi A; Amini A; Farahani RM
Open Access Maced J Med Sci; 2018 Nov; 6(11):1977-1981. PubMed ID: 30559846
[TBL] [Abstract][Full Text] [Related]
8. Chromogenic
Ali AHM; Yahya AQ; Mohammed HL
Open Access Maced J Med Sci; 2019 Jun; 7(12):1917-1925. PubMed ID: 31406529
[TBL] [Abstract][Full Text] [Related]
9. [Comparision of HER2/neu oncogene detected by chromogenic in-situ hybridization and immunohistochemistry in breast cancer].
Zhang GH; Shi DR; Liang XM; Hou JH; Kang SY; Zhu WD; Li XB; Shao Y; Chen LR; Zhou Y
Zhonghua Bing Li Xue Za Zhi; 2006 Oct; 35(10):580-3. PubMed ID: 17134562
[TBL] [Abstract][Full Text] [Related]
10. Chromogenic in situ hybridisation for the assessment of HER2 status in breast cancer: an international validation ring study.
van de Vijver M; Bilous M; Hanna W; Hofmann M; Kristel P; Penault-Llorca F; Rüschoff J
Breast Cancer Res; 2007; 9(5):R68. PubMed ID: 17922920
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of HER2 gene amplification and its protein expression in 165 cases of breast carcinoma: comparison of chromogenic in-situ hybridization and immunohistochemistry].
Shen DH; Wang FH; Yu YZ
Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):457-60. PubMed ID: 17845758
[TBL] [Abstract][Full Text] [Related]
12. Predicting Effects of Clinicopathological Variables on
Hashemi Bahremani M; Ebrahimi A; Fallahi M
Iran J Pathol; 2020; 15(3):217-224. PubMed ID: 32754217
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the prognostic value of multimodal intraoperative monitoring in posterior fossa surgery patients with cerebellopontine angle tumors.
Dalvandi M; Rafie AN; Kamali A; Jamshidifard A
Eur J Transl Myol; 2018 Jan; 28(1):7260. PubMed ID: 29686816
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
